These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1444302)

  • 41. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
    Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
    Int J Antimicrob Agents; 2004 Jul; 24(1):59-66. PubMed ID: 15225863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
    Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
    Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
    Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model.
    Allen GP; Cha R; Rybak MJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2606-12. PubMed ID: 12121940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MIC and serum bactericidal activity of clindamycin against methicillin-resistant and -sensitive staphylococci.
    Lemmen S; Kropec A; Engels I; Busse A; Daschner FD
    Infection; 1993; 21(6):407-9. PubMed ID: 8132374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots.
    Kang SL; Rybak MJ
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2832-4. PubMed ID: 8593034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.
    Finch RG
    Drugs; 1996; 51 Suppl 1():31-7. PubMed ID: 8724814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
    Bouanchaud DH
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():95-9. PubMed ID: 1399956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.
    Munckhof WJ; Giles C; Turnidge JD
    J Antimicrob Chemother; 2001 Jun; 47(6):879-83. PubMed ID: 11389123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
    Sumita Y; Nouda H; Kanazawa K; Fukasawa M
    Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
    Tronel H; Voiriot P; Weber M; Dopff C; Dewachter P; Phelisse F; Dureux JB
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):578-81. PubMed ID: 2797882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.
    Ito T; Matsumoto M; Nishino T
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1522-5. PubMed ID: 7492097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Coudron PE; Jones DL; Dalton HP; Archer GL
    J Clin Microbiol; 1986 Nov; 24(5):764-9. PubMed ID: 3639887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.
    Soussy CJ; Acar JF; Cluzel R; Courvalin P; Duval J; Fleurette J; Megraud F; Meyran M; Thabaut A
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():53-8. PubMed ID: 1399951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime.
    Hansen BG
    Acta Pathol Microbiol Immunol Scand B; 1983 Dec; 91(6):425-9. PubMed ID: 6324530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
    Low DE; Nadler HL
    J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.